Gay, F., Rajkumar, S. V., Coleman, M., Kumar, S., Mark, T., Dispenzieri, A., . . . Niesvizky, R. (2010). Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
Citação norma ChicagoGay, Francesca, et al. Clarithromycin (Biaxin)-lenalidomide-low-dose Dexamethasone (BiRd) Versus Lenalidomide-low-dose Dexamethasone (Rd) for Newly Diagnosed Myeloma. 2010.
MLA CitationGay, Francesca, et al. Clarithromycin (Biaxin)-lenalidomide-low-dose Dexamethasone (BiRd) Versus Lenalidomide-low-dose Dexamethasone (Rd) for Newly Diagnosed Myeloma. 2010.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.